iBio, Inc.
IBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $43,858 | $12,533 | $39,645 | $22,373 |
| - Cash | $28,111 | $8,582 | $4,959 | $7,015 |
| + Debt | $2,572 | $3,508 | $2,931 | $3,997 |
| Enterprise Value | $18,319 | $7,459 | $37,617 | $19,355 |
| Revenue | $100 | $200 | $0 | $200 |
| % Growth | -50% | – | -100% | – |
| Gross Profit | -$189 | $200 | $0 | $200 |
| % Margin | -189% | 100% | – | 100% |
| EBITDA | -$5,395 | -$4,834 | -$4,525 | -$4,026 |
| % Margin | -5,395% | -2,417% | – | -2,013% |
| Net Income | -$5,720 | -$5,163 | -$4,861 | -$4,364 |
| % Margin | -5,720% | -2,581.5% | – | -2,182% |
| EPS Diluted | -0.11 | -0.31 | -0.49 | -0.48 |
| % Growth | 64.5% | 36.7% | -2.1% | – |
| Operating Cash Flow | -$5,665 | -$4,615 | -$3,105 | -$3,869 |
| Capital Expenditures | -$32 | -$1 | -$14 | -$1 |
| Free Cash Flow | -$5,697 | -$4,616 | -$3,119 | -$3,870 |